Run-in period
Run-in period is a term used in clinical trials to describe a preliminary period before the actual study begins. This period is used to stabilize the participants' conditions, eliminate the effects of previous treatments, and establish a baseline for comparison. The run-in period can also be used to assess the participants' compliance and suitability for the study.
Purpose[edit | edit source]
The main purpose of the run-in period is to ensure that all participants start the trial in a similar state. This helps to reduce the variability in the results and increase the accuracy of the findings. The run-in period can also be used to screen out participants who are unlikely to comply with the trial protocol or who experience adverse effects from the treatment.
Types of Run-in Periods[edit | edit source]
There are several types of run-in periods, including:
- Washout period: This is a period during which participants stop taking any previous treatments to eliminate their effects. This is particularly important in trials of new drugs, where the effects of the previous treatment could interfere with the results.
- Placebo run-in period: During this period, all participants are given a placebo to establish a baseline for comparison. This can also help to screen out participants who are likely to drop out of the trial or who experience placebo effects.
- Open-label run-in period: In this type of run-in period, all participants are given the active treatment to assess their response and tolerance. This can help to identify participants who are likely to benefit from the treatment and those who may experience adverse effects.
Criticisms[edit | edit source]
While the run-in period can improve the accuracy of clinical trials, it has also been criticized for potentially biasing the results. For example, by excluding participants who do not respond to the treatment during the run-in period, the trial may overestimate the effectiveness of the treatment. There are also ethical concerns about giving participants a placebo or withdrawing their current treatment during the run-in period.
See also[edit | edit source]
| Run-in period Resources | |
|---|---|
|
 |
Search WikiMD
Ad.Tired of being Overweight? Try W8MD's physician weight loss program.
Semaglutide (Ozempic / Wegovy and Tirzepatide (Mounjaro / Zepbound) available.
Advertise on WikiMD
|
WikiMD's Wellness Encyclopedia |
| Let Food Be Thy Medicine Medicine Thy Food - Hippocrates |
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
Medical Disclaimer: WikiMD is not a substitute for professional medical advice. The information on WikiMD is provided as an information resource only, may be incorrect, outdated or misleading, and is not to be used or relied on for any diagnostic or treatment purposes. Please consult your health care provider before making any healthcare decisions or for guidance about a specific medical condition. WikiMD expressly disclaims responsibility, and shall have no liability, for any damages, loss, injury, or liability whatsoever suffered as a result of your reliance on the information contained in this site. By visiting this site you agree to the foregoing terms and conditions, which may from time to time be changed or supplemented by WikiMD. If you do not agree to the foregoing terms and conditions, you should not enter or use this site. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates Wikipedia, licensed under CC BY SA or similar.
Contributors: Prab R. Tumpati, MD
